KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Restructuring Costs (2016 - 2026)

Medtronic's Restructuring Costs history spans 12 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Restructuring Costs fell 60.0% year-over-year to $12.0 million; the TTM value through Oct 2025 reached $272.0 million, up 21.43%, while the annual FY2025 figure was $267.0 million, 18.14% up from the prior year.
  • Restructuring Costs for Q4 2025 was $12.0 million at Medtronic, down from $67.0 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $294.0 million in Q2 2023 and bottomed at $10.0 million in Q4 2021.
  • The 5-year median for Restructuring Costs is $52.0 million (2021), against an average of $69.8 million.
  • The largest YoY upside for Restructuring Costs was 728.57% in 2021 against a maximum downside of 89.69% in 2021.
  • A 5-year view of Restructuring Costs shows it stood at $10.0 million in 2021, then skyrocketed by 200.0% to $30.0 million in 2022, then soared by 33.33% to $40.0 million in 2023, then fell by 25.0% to $30.0 million in 2024, then plummeted by 60.0% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for MDT's Restructuring Costs are $12.0 million (Q4 2025), $67.0 million (Q3 2025), and $147.0 million (Q2 2025).